Rare diseases
Investigational molecules
Locations
Back to Germany649 clinical trials in Langenau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion
GermanyStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
GermanyStudy on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments
GermanyStudy to Test BI 765845 for Patients with Heart Attack
GermanyStudy on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients
GermanyStudy on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer
GermanyStudy of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer
GermanyStudy on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment
GermanyStudy of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer
GermanyStudy on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer's Disease
GermanyStudy Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions
GermanyStudy on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on plaque psoriasis and psoriatic arthritis, evaluating novel therapeutic approaches for both biologic-naive and experienced patients. Studies aim to assess treatment efficacy in reducing disease symptoms and improving patient outcomes.
Multiple investigations are comparing new therapeutic agents against placebo and established treatments.
Comprehensive studies addressing hidradenitis suppurativa and atopic dermatitis. Research focuses on evaluating new treatments for these challenging conditions, with emphasis on both immediate efficacy and long-term management.
Trials are examining both topical and systemic treatments for optimal disease control.
Innovative research addressing various skin conditions including chronic venous ulcers, actinic keratosis, and rosacea. Studies range from stem cell therapies for wound healing to novel topical treatments.
Research includes both traditional and cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
